Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE

Load latest

Bharat Immunological & Biologicals Corporation Ltd.

18 Apr 2021

21.90

1.01%

Company Update

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Submission Of Information Under Regulation 30 Of …

BSE India

In pursuance to the provision of Regulation 30 of SEBI LODR 2015, it is informed to the Bombay Stock Exchange that the Government of India has decided to support three PSUs including Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) to extend the financial support for production of Covid Vaccine It is submitted for information and record of the Exchange please

pdf

Bharat Immunological & Biologicals Corporation Ltd.

12 Apr 2021

21.90

1.01%

Company Update

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Shareholding for the Period Ended March 31, 2021

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

08 Apr 2021

21.90

1.01%

Company Update

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Statement Of Investor Complaints For The Quarter Ended March 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SANDIP KUMAR LALDesignation :- Company Secretary and Compliance Officer

Bharat Immunological & Biologicals Corporation Ltd.

08 Apr 2021

21.90

1.01%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd

BSE India

The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on April 8, 2021, with reference to news appeared in economictimes.indiatimes.com dated April 8, 2021 quoting "Panacea in talks with Bharat Biotech to make Covaxin".The reply is awaited.

Bharat Immunological & Biologicals Corporation Ltd.

15 Feb 2021

21.90

1.01%

Result

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Submission Of Limited Review Report Of The …

BSE India

In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 31st December 2020.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

11 Feb 2021

21.90

1.01%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Submission Of Unaudited Quarterly Financial Results (UAFR) …

BSE India

In pursuance of the LODR with Stock Exchange, please find enclosed the UAFR for the quarter ended and nine months ended December 2020 approved by the Board of the Company in its Meeting on 10.02.2021.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

03 Feb 2021

21.90

1.01%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Board Meeting Intimation for Intimation Of Date …

BSE India

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 10th February 2021, to approve the Unaudited Quarterly Financial Results of the Company for the quarter ended 31st December 2020.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

11 Jan 2021

21.90

1.01%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Shareholding for the Period Ended December 31, 2020

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

11 Jan 2021

21.90

1.01%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Statement Of Investor Complaints For The Quarter Ended December 2020

BSE India

Bharat Immunological & Biologicals Corporation Ltd.

11 Jan 2021

21.90

1.01%

Corp. Note

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Reg. 34 (1) Annual Report

BSE India

In pursuance of the provision of Regulation 34(1) of the Listing Regulation (LODR) 2015, please find attached herewith the Annual Report 2019-20 being approved and adopted in annual general meeting as per the provisions of the Companies Act, 2013.

pdf

No results found

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%

38.96% Fall from 52W High

Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE